Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.73), versus ($0.42) reported last year. Revenue for the quarter came in at $140.59 million, versus $109.13 million reported last year.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.